Parkinson’s Pills Turn Patients into Gambling Addicts: UK Authorities Demand Drug Label Reviews

A recent journalistic investigation conducted by BBC revealed alarming statistics: more than 250 patients have experienced severe impulse control disorders, with uncontrollable gambling urges at the top of the list. As it turned out, the cause of this condition was the use of specific medications, dopamine receptor agonists.

At the centre of the scandal is the drug ropinirole, marketed under the brand name Requip by the pharmaceutical company GSK. This medication is commonly prescribed to people suffering from restless legs syndrome and Parkinson's disease.

What makes this situation especially outrageous is that the scientific community confirmed a direct link between the use of these drugs and the development of compulsive gambling as far back as 2017. Nevertheless, in practice, treating physicians continue to act negligently and fail to properly warn patients about such serious and destructive side effects.

The situation has now escalated to the highest levels of government. Just last week, the chair of the parliamentary health committee officially addressed the Medicines and Healthcare products Regulatory Agency (MHRA). The main demand from lawmakers is an immediate revision of labelling rules for these medications and stricter warnings about potential risks in order to protect both the health and financial well-being of citizens.